Ag348-C-018
Research payments
$1,481,976
Through program year 2025, $1,481,976 in research payments was reported against Ag348-C-018, across 217 payments, paid by Agios Pharmaceuticals, Inc..
- Paid by
- Agios Pharmaceuticals, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $431,626 | 80 |
| 2024 | Research | $333,210 | 52 |
| 2023 | Research | $366,251 | 57 |
| 2022 | Research | $350,889 | 28 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- May Chien Palo Alto, CA Named on 35 payments
- Kleber Yotsumoto Fertrin Seattle, WA Named on 29 payments
- John Strouse Durham, NC Named on 21 payments
- Sanjay Shah Mesa, AZ Named on 18 payments
- Farzana Sayani Philadelphia, PA Named on 18 payments
- Erica Esrick Boston, MA Named on 17 payments
- Alexander Glaros Detroit, MI Named on 15 payments
- Srila Gopal La Jolla, CA Named on 15 payments
- Ashutosh Lal Oakland, CA Named on 14 payments
- Sujit Sheth New York, NY Named on 10 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.